Hence, we hypothesised that polymorphisms in LEP and LEPR could lead to an increased risk for differentiated thyroid cancer (DTC), thus establishing the link between the observed epidemiological increases in both thyroid cancer and obesity rates. Here, LEPR is linked to obesity due to melanocortin 4 receptor deficiency.